{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-23-000366","form_type":"8-K","ticker":"ACHC","cik":"0001520697","company_name":"Acadia Healthcare Company, Inc.","filed_at":"2023-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.371203+00:00","generated_at":"2026-06-18T23:31:37.042019+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Acadia Healthcare Q4 revenue up 13.8% to $675.3M; guides FY2023 adj. EPS $3.10-3.40","bullets":["Q4 net income $61.1M ($0.67 diluted EPS); adjusted EPS $0.74, including $0.04 from CARES Act PRF.","Same facility revenue +9.4% YoY on 5.2% revenue per patient day and 4.0% patient day growth.","FY2023 guidance: revenue $2.82-2.88B, adj. EBITDA $635-675M, adj. EPS $3.10-3.40.","Q1 2023 guidance: revenue $690-700M, adj. EBITDA $145-150M, adj. EPS $0.70-0.74.","Added 80 beds in Q4; opened joint venture facility in Ft. Wayne and acquired four CTCs in Georgia."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-23-000366","json":"https://secwatch.observer/filing/0001157523-23-000366.json","markdown":"https://secwatch.observer/filing/0001157523-23-000366.md","text":"https://secwatch.observer/filing/0001157523-23-000366.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1520697/000115752323000366/0001157523-23-000366-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1520697/000115752323000366/a53352529.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T23:31:37.042019+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ac344d01cd30b352546068abaf8ff66126b344ab","claim":"Acadia Healthcare Company, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $675.3 million, net income $61.1 million, EPS $0.67 per diluted share. Guidance initiated.","evidence_excerpt":"Revenue totaled $675.3 million, an increase of 13.8% over the fourth quarter of 2021 Same facility revenue increased 9.4% compared to the fourth quarter of 2021, including an increase in revenue per patient day of 5.2% and an increase in patient days of 4.0% Net income attributable to Acadia totaled $61.1 million, or $0.67 per diluted share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1520697/000115752323000366/0001157523-23-000366-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$675.3 million"},{"label":"Net income","value":"$61.1 million"},{"label":"EPS","value":"$0.67 per diluted share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}